European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Olaparib
Related studies linked through entity extraction aliases.
A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC
- Status
- WITHDRAWN
- Phase
- PHASE1
Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Olaparib in Treating Patients With Stage IV Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
- Status
- COMPLETED
- Phase
- PHASE2
AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of PARPi to Treat Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Olaparib Endometrial Carcinoma Study (POLEN)
- Status
- COMPLETED
- Phase
- N/A
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3